首页> 美国卫生研究院文献>other >Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson’s disease genes
【2h】

Trumping neurodegeneration: Targeting common pathways regulated by autosomal recessive Parkinson’s disease genes

机译:反对神经退行性变:靶向常染色体隐性帕金森氏病基因调控的常见途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Parkinson’s disease (PD) is a neurodegenerative movement disorder characterized by the progressive loss of dopaminergic (DA) neurons. Most PD cases are sporadic; however, rare familial forms have been identified. Autosomal recessive PD (ARPD) results from mutations in Parkin, PINK1, DJ-1, and ATP13A2, while rare, atypical juvenile ARPD result from mutations in FBXO7, DNAJC6, SYNJ1, and PLA2G6. Studying these genes and their function has revealed mitochondrial quality control, protein degradation processes, and oxidative stress responses as common pathways underlying PD pathogenesis. Understanding how aberrancy in these common processes leads to neurodegeneration has provided the field with numerous targets that may be therapeutically relevant to the development of disease-modifying treatments.
机译:帕金森氏病(PD)是一种神经退行性运动障碍,其特征是多巴胺能(DA)神经元逐渐丧失。大多数PD病例是偶发性的;但是,已经确定了罕见的家族形式。常染色体隐性PD(ARPD)是由Parkin,PINK1,DJ-1和ATP13A2的突变引起的,而罕见的非典型少年ARPD是由FBXO7,DNAJC6,SYNJ1和PLA2G6的突变引起的。对这些基因及其功能的研究表明,线粒体质量控制,蛋白质降解过程和氧化应激反应是PD发病机理的常见途径。了解这些常见过程中的异常如何导致神经退行性变,为该领域提供了许多靶标,这些靶标可能与疾病缓解疗法的开发在治疗上相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号